3 online COVID trackers to bookmark now and check whenever

Dave Pearson | | Health Exec | COVID-19
USA

This week NPR has posted three interactive infographics that health execs may find especially valuable as COVID-19 surges in spots across the U.S. and around the world.

Part of the broadcaster’s “Coronavirus by the Numbers” series, the new items are regularly updated and worth a daily or weekly look:

1. U.S. map showing where counties stand on hospital capacity

2. World map with country-by-country counts of new cases, new cases per 100,000 residents, total cases and total cases per 100,000

3. Heat map indicating COVID risk level by four color-coded categories

NPR started the series in the spring and has archived it as an ongoing collection.

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

Monitoring acute heart patients at home linked to considerable cost savings
Brazen marital healthcare scheme ends with guilty pleas
CityMD agrees to $12M settlement over alleged COVID claims fraud
Q&A: Cardiologist Karen Joynt Maddox on why new healthcare policies are not improving outcomes
Does Covid-19 raise risk for cancers—including rare ones?
FDA panel recommends new COVID-19 booster

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.